Avestar Capital, LLC Guardant Health, Inc. Transaction History

Avestar Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$28.82 - $77.35 $138,451 - $371,589	-4,804 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$48.25 - $100.49 $35,270 - $73,458	-731 Reduced 13.21%	4,804 $318,000
Q4 2021 Feb 01, 2022	BUY	$88.71 - $120.43 $19,161 - $26,012	216 Added 4.06%	5,535 $554,000
Q3 2021 Nov 09, 2021	BUY	$98.77 - $132.17 $52,841 - $70,710	535 Added 11.18%	5,319 $665,000
Q2 2021 Aug 03, 2021	BUY	$109.77 - $165.68 $27,662 - $41,751	252 Added 5.56%	4,784 $594,000
Q1 2021 May 03, 2021	BUY	$127.04 - $179.1 $191,576 - $270,082	1,508 Added 49.87%	4,532 $745,000
Q4 2020 Feb 01, 2021	BUY	$99.96 - $135.93 $70,271 - $95,558	703 Added 30.29%	3,024 $390,000
Q3 2020 Oct 29, 2020	BUY	$80.32 - $111.8 $186,422 - $259,487	2,321 New	2,321 $239,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.24B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.